Literature DB >> 2625093

Secretory IgA and lysozyme in tears of patients with Graves' ophthalmopathy.

H A Khalil1, R J De Keizer, V M Bodelier, A Kijlstra.   

Abstract

Using an enzyme linked immuno-assay (ELISA) and spectrophotometry, we determined levels of secretory IgA and lysozyme in tears of 69 patients with Graves' ophthalmopathy and 28 controls. The quantitative determination of secretory IgA and lysozyme in tears provided an impression of the functioning of the lacrimal gland in the two groups. An IgA/lysozyme ratio was calculated in both patients and controls as a parameter for the activity of the secretory IgA-producing plasma cells in the lacrimal gland. An increase in the IgA/lysozyme ratio was observed in 23 patients (33%) and one control (3%). Half of the patients who had suffered from the disease for more than 5 years showed a raised IgA/lysozyme ratio. No correlation was found between the IgA/lysozyme ratio and the NOSPECS classification. Our findings suggest that the lacrimal gland is involved in the orbital condition produced by Graves' ophthalmopathy. In most cases the involvement occurs in patients with a long history of the disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2625093     DOI: 10.1007/bf00153500

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  4 in total

1.  Analysis of tear proteins in Graves' ophthalmopathy by high performance liquid chromatography.

Authors:  H A Khalil; R J de Keizer; A Kijlstra
Journal:  Am J Ophthalmol       Date:  1988-08-15       Impact factor: 5.258

2.  Modification of the classification of the eye changes of Graves' disease.

Authors:  S C Werner
Journal:  Am J Ophthalmol       Date:  1977-05       Impact factor: 5.258

Review 3.  Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis, and treatment.

Authors:  D H Jacobson; C A Gorman
Journal:  Endocr Rev       Date:  1984       Impact factor: 19.871

4.  Correlation of CT scanning and pathologic features of ophthalmic Graves' disease.

Authors:  S L Trokel; F A Jakobiec
Journal:  Ophthalmology       Date:  1981-06       Impact factor: 12.079

  4 in total
  12 in total

1.  Histopathologic analysis of palpebral conjunctiva in thyroid-related orbitopathy (an american ophthalmological society thesis).

Authors:  Don O Kikkawa
Journal:  Trans Am Ophthalmol Soc       Date:  2010-12

2.  The permeability of the corneal epithelium of Graves' ophthalmopathy as determined by fluorophotometry.

Authors:  H A Khalil; J A van Best; R J de Keizer
Journal:  Doc Ophthalmol       Date:  1989-11       Impact factor: 2.379

3.  Inflammatory cytokine profiles in the tears of thyroid-associated ophthalmopathy.

Authors:  Danping Huang; Nuo Xu; Yiyue Song; Peijuan Wang; Huasheng Yang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-11-30       Impact factor: 3.117

Review 4.  The potential of tear proteomics for diagnosis and management of orbital inflammatory disorders including Graves' ophthalmopathy.

Authors:  Hadi Khazaei; Danesh Khazaei; Rohan Verma; John Ng; Phillip A Wilmarth; Larry L David; James T Rosenbaum
Journal:  Exp Eye Res       Date:  2021-11-03       Impact factor: 3.467

5.  The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy.

Authors:  Luigi Bartalena; Lelio Baldeschi; Kostas Boboridis; Anja Eckstein; George J Kahaly; Claudio Marcocci; Petros Perros; Mario Salvi; Wilmar M Wiersinga
Journal:  Eur Thyroid J       Date:  2016-03-02

6.  Intolerant contact lens wearers exhibit ocular surface impairment despite 3 months wear discontinuation.

Authors:  Giuseppe Giannaccare; William Blalock; Michela Fresina; Aldo Vagge; Piera Versura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-06-09       Impact factor: 3.117

7.  Interleukin-7 expression in tears and orbital tissues of patients with Graves' ophthalmopathy.

Authors:  KeBo Cai; RuiLi Wei
Journal:  Endocrine       Date:  2012-11-28       Impact factor: 3.633

Review 8.  The relationship between Graves' ophthalmopathy and dry eye syndrome.

Authors:  Jessica H Selter; Anisa I Gire; Shameema Sikder
Journal:  Clin Ophthalmol       Date:  2014-12-31

9.  Establishment of a tear protein biomarker panel differentiating between Graves' disease with or without orbitopathy.

Authors:  Cecilie Aass; Ingrid Norheim; Erik Fink Eriksen; Ellen Charlotte Børnick; Per Medbøe Thorsby; Milaim Pepaj
Journal:  PLoS One       Date:  2017-04-18       Impact factor: 3.240

10.  Patient acceptability of tear collection in the primary healthcare setting.

Authors:  Joanne Hui Min Quah; Louis Tong; Sylvaine Barbier
Journal:  Optom Vis Sci       Date:  2014-04       Impact factor: 1.973

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.